Male Partner Involvement in the Prevention of MTCT of HIV
|HIV Infections||Behavioral: Voluntary counselling and HIV testing in ANC for PMTCT Behavioral: VCT||Phase 4|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Screening
|Official Title:||Optimizing the Impact of Prevention of Mother to Child Transmission of HIV in South Africa: the Forgotten Half of the Equation.|
- Percentage of partners agreeing to attend VCT. [ Time Frame: 12 weeks ]
- Percentage of partners and pregnant women abstaining, faithful to one partner and using condoms consistently. [ Time Frame: 12 weeks ]
|Study Start Date:||November 2006|
|Study Completion Date:||May 2008|
|Primary Completion Date:||December 2007 (Final data collection date for primary outcome measure)|
Behavioral: Voluntary counselling and HIV testing in ANC for PMTCT
- ANC VCT
- VCT for PMTCT
We will enrol 1000 pregnant women; recruited from antenatal clinic at Khayelitsha Midwive and Obstetric Unit (MOU). Community sensitization activities will be implemented in the catchment community to encourage male partner participation.
At the booking visit all women will be offered antenatal care, HIV group education and VCT as usual. Thereafter women will be recruited to enrol into the study, after signing the consent form half of the cohort members will be randomly assigned to partner VCT (Group A) and half to partner pregnancy information (Group B). Men in group B will be offered VCT at the second interview late in pregnancy. However, VCT will be provided if requested by study participants at any stage of the study or if the female partner is HIV positive. Women in group A will be given a written invitation to hand to their partners to encourage them to invite their partners to come to the antenatal clinic for VCT. In group B, women will be given a written invitation to give to their partners to encourage their partners to attend a pregnancy information session at the antenatal clinic.
VCT will be offered again close to delivery for all women and men who were previously uninfected or of unknown status. For those found to be HIV-infected at a prior visit, CD4 and CD8 T-cell counts, viral load, and full blood count tests will be conducted. Both women and men will be referred to the Antiretroviral clinic where ARV will be offered if appropriate and formula feeding (or exclusive breastfeeding) will be recommended. Reasons for declining VCT and data on sexual behaviour and violence will be sought at each visit.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00405990
|Khayelitsha Midwive and Obstetric Unit Site B|
|Cape Town, Western Cape, South Africa, 7784|
|Principal Investigator:||Boshishi K Mohlala, MBCHB FCOG MSC||Imperial College London|